IL33 and familial pancreatic carcinoma: Subsequent in vitro and in vivo work on multiple cancer types have confirmed these findings, with a similar IL-33-induced immuno-suppressive microenvironment reported to play a tumor-promoting role in, amongst others, CRC, gastric cancer, lung cancer, head and neck cancers, pancreatic cancers and cervical cancer (93).